Page 95 - Pagetit
P. 95

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE




                   Mechanism of action
                   Benzodiazepines act by binding to a specific binding site on the GABA-A
                   receptor complex, which facilitates the effects of GABA on the opening of
                   the chloride channel (Haefely, 1978). Barbiturates also bind to a separate
                   specific site on the GABA-A receptor and directly open the chloride channel
                   (Nutt & Malizia, 2001). Benzodiazepines do not directly open the channel,
                   but they modulate the ability of GABA to do so, thus less GABA than usual
                   is required to open the channel (Barnard et al., 1998). The effects of
                   benzodiazepines on endogenous GABA function makes them safer in large
                   doses than the barbiturates and alcohol. The latter directly open the chloride
                   channel and therefore can have effects in excess of the naturally occurring
                   effects of GABA.
                     The increase in chloride conductance following opening of the chloride
                   channel hyperpolarizes the cell, making it less likely to fire an action potential
                   (see Chapter 2). Because GABA controls neuronal excitability in all brain
                   regions, increasing GABA function is the mechanism by which sedatives and
                   hypnotics have their characteristic effects of sedation, amnesia and motor
                   incoordination (Nutt & Malizia, 2001).
                     Like other dependence-producing drugs, there is also evidence that
                   sedatives and hypnotics affect the mesolimbic dopamine system
                   (Feigenbaum & Yanai, 1983), leading to their reinforcing effects and enhancing
                   the motivation to repeat their use.
                     Similarly to alcohol, the benzodiazepine lorazepam decreases metabolic
                   activity in the occipital cortex, increases activity in the temporal cortex, and
                   also decreases thalamic metabolism, as measured by positron emission
                   tomography (Wang et al., 2000).


                   Tolerance and withdrawal
                   Tolerance to the effects of sedatives/hypnotics develops rapidly, and increased
                   doses are required to maintain the same level of effect. Tolerance develops to
                   the pleasurable and sedative effects, as well as to the effects of benzodiazepines
                   and barbiturates on motor coordination. Tolerance to the anticonvulsant effects
                   does not appear to occur (Jacobs & Fehr, 1987). There is also a high degree of
                   cross-tolerance between sedatives/hypnotics, including alcohol.
                     Upon withdrawal of sedatives and hypnotics, certain effects are observed
                   which are opposite to those of the drug. Thus, increased arousal, anxiety,
                   restlessness, insomnia and excitability are characteristic withdrawal
                   symptoms (Nutt & Malizia, 2001). In severe cases, seizures can occur.
                     There is evidence that chronic treatment with benzodiazepines alters the
                   composition of GABA-A receptor subunits (Holt, Bateson & Martin, 1996),
                   which may also be due to changes in receptor coupling and function. This
                   results in tolerance in the presence of benzodiazepines, and withdrawal
                   symptoms when benzodiazepines are removed.


                                                  74




          Chapter_4                74                              19.1.2004, 11:42
   90   91   92   93   94   95   96   97   98   99   100